FDA Approves Guardant360® Cdx For Eli Lilly`s Inluriyo
29 Sep 2025 //
BUSINESSWIRE
FDA Approves Inluriyo for Adults Metastatic Breast Cancer
26 Sep 2025 //
PR NEWSWIRE
Eli Lilly`s Inluriyo Receives Approval in US
25 Sep 2025 //
FDA
Lilly to Present Imlunestrant Results at Breast Cancer Symposium
01 Nov 2024 //
PR NEWSWIRE